Who Paid My Doc
Ranexa
Drug Ihd
NDC 61958-1003-1
General payments
$4,973
Research payments
$279,235
Through program year 2021, $4,973 in general payments and $279,235 in research payments were reported against Ranexa (Ihd).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $87,151 | 5 |
| 2020 | Research | $102,085 | 6 |
| 2019 | General | $4,973 | 358 |
| 2019 | Research | $89,998 | 6 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.
The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2019 where a state was reported.
Records
358 general · 17 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.